scholarly journals A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis

Allergy ◽  
2017 ◽  
Vol 72 (10) ◽  
pp. 1565-1575 ◽  
Author(s):  
K. Okubo ◽  
K. Hashiguchi ◽  
T. Takeda ◽  
K. Baba ◽  
H. Kitagoh ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document